Quality of life in sarcoidosis: Assessment and management

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 4, 2010, Pages 485-493

  De Vries, Jolanda ^a,b,c   Lower, Elyse E ^d   Drent, Marjolein ^c  

^a TILBURG UNIVERSITY   (Netherlands)

^b CPRLab   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

assessment; Fatigue; management; quality of life; sarcoidosis

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DEXMETHYLPHENIDATE; FLUTICASONE; ILOPROST; INFLIXIMAB; METHYLPHENIDATE; MODAFINIL; PREDNISONE; THALIDOMIDE;

CLINICAL TRIAL; FATIGUE; FATIGUE ASSESSMENT SCALE; HEALTH STATUS; HUMAN; LUNG FUNCTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SARCOIDOSIS; SOCIAL ASPECT; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE;

FATIGUE; HEALTH STATUS; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SARCOIDOSIS;

EID: 77955048423     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1262216     Document Type: Review

References (69)

1. Iannuzzi M C., Rybicki B A., Teirstein A S. Sarcoidosis. N Engl J Med 2007 357 2153-2165
2. Wirnsberger R M., de Vries J, Wouters E F., Drent M. Clinical presentation of sarcoidosis in the Netherlands an epidemiological study. Neth J Med 1998 53 53-60
3. Drent M, Wirnsberger R M., Breteler M H., Kock L M., de Vries J, Wouters E F. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998 15 59-66
4. Wirnsberger R M., de Vries J, Breteler M H., van Heck G L., Wouters E F., Drent M. Evaluation of quality of life in sarcoidosis patients. Respir Med 1998 92 750-756
5. De Vries J, Wirnsberger R M. Fatigue, quality of life, and health status in sarcoidosis. European Respiratory Society Monograph 2005 32 92-104
6. Michielsen H J., Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007 74 401-405
7. Elfferich M D., Nelemans P J., Ponds R W., De Vries J, Wijnen P A., Drent M. Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF- treatment. Respiration 2010 Apr 29. [Epub ahead of print]
8. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001 357 7-8
9. Curtis J R., Patrick D L. The assessment of health status among patients with COPD. Eur Respir J Suppl 2003 41 36s-45s
10. De Vries J, Seebregts A, Drent M. Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med 2000 94 273-278
11. Breek J C., de Vries J, van Heck G L., van Berge Henegouwen D P., Hamming J F. Assessment of disease impact in patients with intermittent claudication: discrepancy between health status and quality of life. J Vasc Surg 2005 41 443-450
12. Testa M A. Methods and applications of quality-of-life measurement during antihypertensive therapy. Curr Hypertens Rep 2000 2 530-537
13. Montazeri A, Milroy R, Gillis C R., McEwen J. Quality of life: perception of lung cancer patients. Eur J Cancer 1996 32A 2284-2289
14. World Health Organization. Facet Definition and Questions: Field Trial WHOQOL-100. Geneva WHO 1995
15. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995 41 1403-1409
16. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993 29 321-326
17. Ritsner M, Kurs R, Kostizky H, Ponizovsky A, Modai I. Subjective quality of life in severely mentally ill patients: a comparison of two instruments. Qual Life Res 2002 11 553-561
18. Guyatt G H., Berman L B., Townsend M, Pugsley S O., Chambers L W. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987 42 773-778
19. Guyatt G H., Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 1989 83 293-297
20. Wijkstra P J., TenVergert E M., Van Altena R et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994 49 465-467
21. Chang J A., Curtis J R., Patrick D L., Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999 116 1175-1182
22. Ware J E., Snow K K., Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston Quality Metric 1993
23. Bowling A. Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales. Buckingham Open University Press 1995
24. Cox C E., Donohue J F., Brown C D., Kataria Y P., Judson M A. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med 2003 168 323-329
25. Bergner M, Bobbitt R A., Carter W B., Gilson B S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981 19 787-805
26. Jones P W., Quirk F H., Baveystock C M. The St George's Respiratory Questionnaire. Respir Med 1991 85 (Suppl B) 25-31 discussion 33-37
27. Jones P W., Bosh T K. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997 155 1283-1289
28. Jones P W., Nedocromil Sodium Quality of Life Study Group. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Eur Respir J 1994 7 55-62
29. Jones P W., Quirk F H., Baveystock C M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. Georges Respiratory Questionnaire. Am Rev Respir Dis 1992 145 1321-1327
30. Cox C E., Donohue J F., Brown C D., Kataria Y P., Judson M A. Health-related quality of life of persons with sarcoidosis. Chest 2004 125 997-1004
31. Wirnsberger R M., De Vries J, Jansen T L., Van Heck G L., Wouters E F., Drent M. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med 1999 54 86-95
32. Antoniou K M., Tzanakis N, Tzouvelekis A et al. Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med 2006 17 421-426
33. Michielsen H J., De Vries J, Drent M, Peros-Golubicic T. Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 133-138
34. De Vries J, Van Heck G L., Drent M. Gender differences in sarcoidosis: symptoms, quality of life, and medical consumption. Women Health 1999 30 99-114
35. Gvozdenovic B S., Mihailovic-Vucinic V, Ilic-Dudvarski A, Zugic V, Judson M A. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med 2008 102 1636-1642
36. Goracci A, Fagiolini A, Martinucci M et al. Quality of life, anxiety and depression in sarcoidosis. Gen Hosp Psychiatry 2008 30 441-445
37. Michielsen H J., Drent M, Peros-Golubicic T, De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006 130 989-994
38. De Vries J, Drent M, Van Heck G L., Wouters E F. Quality of life in sarcoidosis: a comparison between members of a patient organisation and a random sample. Sarcoidosis Vasc Diffuse Lung Dis 1998 15 183-188
39. Baughman R P., Sparkman B K., Lower E E. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007 132 207-213
40. Wirnsberger R M., Drent M, Hekelaar N et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997 10 1450-1455
41. Spruit M A., Thomeer M J., Gosselink R et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005 60 32-38
42. Yeager H, Rossman M D., Baughman R P. et al, ACCESS Research Group. Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 147-153
43. Baughman R P., Iannuzzi M C., Lower E E. et al. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002 19 198-204
44. de Kleijn W PE, Elfferich M DP, De Vries J et al. Fatigue in sarcoidosis: American versus Dutch patients. Sarcoidosis Vasc Diffuse Lung Dis 2009 26 92-97
45. de Kleijn W P., De Vries J, Lower E E., Elfferich M D., Baughman R P., Drent M. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med 2009 15 499-506
46. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003 160 221-236
47. Drent M, Wirnsberger R M., de Vries J, van Dieijen-Visser M P., Wouters E F., Schols A M. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 1999 13 718-722
48. De Vries J, Michielsen H, Van Heck G L., Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004 9 (Pt 3) 279-291
49. Hoitsma E, De Vries J, van Santen-Hoeufft M, Faber C G., Drent M. Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis 2003 20 33-39
50. Hoitsma E, Faber C G., Drent M, Sharma O P. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004 3 397-407
51. Lower E E., Weiss K L. Neurosarcoidosis. Clin Chest Med 2008 29 475-492, ix
52. Drent M, Verbraecken J, van der Grinten C, Wouters E. Fatigue associated with obstructive sleep apnea in a patient with sarcoidosis. Respiration 2000 67 337-340
53. Turner G A., Lower E E., Corser B C., Gunther K L., Baughman R P. Sleep apnea in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997 14 61-64
54. Verbraecken J, Hoitsma E, van der Grinten C P., Cobben N A., Wouters E F., Drent M. Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004 21 137-146
55. Devigili G, Tugnoli V, Penza P et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008 131 (Pt 7) 1912-1925
56. Goldstein D S., Robertson D, Esler M, Straus S E., Eisenhofer G. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 2002 137 753-763 (Pubitemid 35265320)
57. Hoitsma E, Faber C G., van Santen-Hoeufft M, De Vries J, Reulen J P., Drent M. Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2006 23 73-77
58. Lower E E., Harman S, Baughman R P. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest 2008 133 1189-1195
59. Chalder T, Berelowitz G, Pawlikowska T et al. Development of a fatigue scale. J Psychosom Res 1993 37 147-153
60. Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry 1997 154 408-414 (Pubitemid 27098293)
61. Lower E E., Fleishman S, Cooper A et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage 2009 38 650-662
62. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 2001 161 411-420
63. Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 2006 119 167.e23-30
64. Wagner M T., Marion S D., Judson M A. The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 235
65. De Vries J. Quality of life assessment In: Vingerhoets AJJM Assessment in Behavioral Medicine. Hove Brunner-Routledge, UK 2001 353-370
66. Baughman R P., Drent M, Kavuru M et al, Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006 174 795-802
67. Rossman M D., Newman L S., Baughman R P. et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 23 201-208
68. Judson M A., Silvestri J, Hartung C, Byars T, Cox C E. The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 23 51-57
69. Baughman R P., Judson M A., Lower E E. et al. Inhaled iloprost for sarcoidosis associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis 2009 26 110-120